Cirrhosis is a condition in which scar tissue gradually replaces your healthy liver cells. It usually happens over a long period, often due to hepatitis, alcohol use disorder, or metabolic ...

Cirrhosis When excessive scar tissue forms, fibrosis becomes irreversible, leading to cirrhosis. Chronic liver diseases, hepatitis, and alcohol use can cause cirrhosis. Without treatment ...

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury, cholestasis and ...

In the recent years, there have been an increasing number of reports on favourable effects of statins in patients with advanced chronic liver disease. These include reduction in portal pressure, ...

Peripheral stigmata of chronic liver disease should raise the suspicion of underlying cirrhosis. As many as 70% of patients with moderate or severe alcoholic hepatitis by laboratory parameters ...

However, where it fell short was with respect to the failure at week 36 with the phase 2b SYMMETRY study, which used EFX to treat compensated cirrhosis patients due to MASH stage F4 fibrosis.

Liver Disease-Focused Akero Therapeutics Stock Soars Over 100% On Monday - Here's Why On Monday, Akero Therapeutics, Inc. (NASDAQ:AKRO) released preliminary topline week 96 results from SYMMETRY ...

In 2022, more than 941,600 Americans died from cardiovascular disease. Heart disease remains the leading cause of death in the United States, according to a new report. The American Heart ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study offers one available option: bariatric surgery. Weight loss operations ...

Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity. ScienceDaily . Retrieved February 17, 2025 from www.sciencedaily.com / releases ...

Akero Therapeutics reported Monday strong results from a nearly two-year, placebo-controlled study showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused by the ...